Zolpidem Tartrate
Product Images NDC 61919-955

2 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 61919-955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Module)

Image Description (Module)
Chemical structure of zolpidem tartrate, showing two components: the zolpidem molecule on the left and the tartrate ion on the right. The molecular diagram includes labeled atoms and bond connections representing the chemical composition.*
FDA Label Image

Image Description (Zolpidemtar955)

Image Description (Zolpidemtar955)
Zolpidem Tartrate ER C-IV 12.5mg tablet packaging label by Direct RX, containing 30 tablets. The label indicates the product is a generic form of Ambien, with each tablet containing 12.5mg of extended-release Zolpidem Tartrate. Packaging includes lot number 955-30 and discard date 07/17. Dosage instructions note it should be taken with plenty of water and warn about possible drowsiness or dizziness.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.